Cartesian Therapeutics
RNAC
#6732
Rank
โ‚ฌ0.43 B
Marketcap
18,12ย โ‚ฌ
Share price
3.61%
Change (1 day)
-41.06%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -โ‚ฌ0.23 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are โ‚ฌ54.1 Million. In 2023 the company made an earning of -โ‚ฌ0.22 Billion a decrease over its 2022 earnings that were of โ‚ฌ34.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.23 Billion4.21%
2023 -โ‚ฌ0.22 Billion-724%
2022 โ‚ฌ34.58 M-649.67%
2021 -โ‚ฌ6.3 Million-89.78%
2020 -โ‚ฌ61.6 Million25.06%
2019 -โ‚ฌ49.26 Million-15.68%
2018 -โ‚ฌ58.42 Million-0.43%
2017 -โ‚ฌ58.67 Million83.41%
2016 -โ‚ฌ31.99 Million44.3%
2015 -โ‚ฌ22.17 Million